News Image

Amneal Reports Third Quarter 2025 Financial Results

Provided By GlobeNewswire

Last update: Oct 30, 2025

Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01
‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17
‒ Updated 2025 Full Year Guidance ‒

Read more at globenewswire.com

AMNEAL PHARMACEUTICALS INC

NASDAQ:AMRX (11/13/2025, 8:15:29 PM)

After market: 11.7685 +0.25 (+2.16%)

11.52

-0.38 (-3.19%)



Find more stocks in the Stock Screener

AMRX Latest News and Analysis

Follow ChartMill for more